Clinical stage molecule PT150 is a modulator of glucocorticoid and androgen receptors with antiviral activity against SARS-CoV-2.

PT150 is a clinical-stage molecule, taken orally, with a strong safety profile having completed Phase 1 and Phase 2 clinical trials for its original use as an antidepressant. It has an active IND for COVID-19. Antiviral activities have been found for PT150 and other members of its class in a variety...

Descripción completa

Detalles Bibliográficos
Autores principales: Theise, Neil D., Arment, Anthony R., Chakravarty, Dimple, Gregg, John M. H., Jacobson, Ira M., Jung, Kie Hoon, Nair, Sujit S., Tewari, Ashutosh K., Thurston, Archie W., Van Drie, John, Westover, Jonna B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738205/
https://www.ncbi.nlm.nih.gov/pubmed/33305659
http://dx.doi.org/10.1080/15384101.2020.1859752

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738205/
https://www.ncbi.nlm.nih.gov/pubmed/33305659
http://dx.doi.org/10.1080/15384101.2020.1859752

Ejemplares similares